Select Publications
Journal articles
2014, 'Metal and complementary molecular bioimaging in alzheimer's disease', Frontiers in Aging Neuroscience, 6, http://dx.doi.org/10.3389/fnagi.2014.00138
,2014, 'Alpha-Synuclein Transmission and Mitochondrial Toxicity in Primary Human Foetal Enteric Neurons In Vitro', Neurotoxicity Research, 25, pp. 170 - 182, http://dx.doi.org/10.1007/s12640-013-9420-5
,2014, 'Association of leukocyte telomere length with vascular dementia and cancer mortality in an elderly population.', Journal of the American Geriatrics Society, 62, pp. 1384 - 1386, http://dx.doi.org/10.1111/jgs.12910
,2014, 'NEUROPROTECTIVE EFFECTS OF A VARIETY OF POMEGRANATE JUICE EXTRACTS (PJE) AGAINST THE EXCITOTOXIN QUINOLINIC ACID IN HUMAN PRIMARY NEURONS', The Journal of Prevention of Alzheimer's disease, 1, pp. 84 - 90, http://dx.doi.org/10.14283/jpad.2014.3
,2014, 'REVIEW OF NATURAL PRODUCTS ON PARKINSON’S DISEASE PATHOLOGY', Journal of Aging Research and Lifestyle, pp. 1 - 10, http://dx.doi.org/10.14283/jarcp.2014.23
,2013, 'Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis', Brain Research, 1537, pp. 267 - 272, http://dx.doi.org/10.1016/j.brainres.2013.08.025
,2013, 'Neuroprotective effects of a variety of pomegranate juice extracts against MPTP-induced cytotoxicity and oxidative stress in human primary neurons', Oxidative Medicine and Cellular Longevity, http://dx.doi.org/10.1155/2013/685909
,2013, 'Types and sociodemographic correlates of complementary and alternative medicine (CAM) use among people with epilepsy in Oman', Epilepsy and Behavior, 29, pp. 361 - 366, http://dx.doi.org/10.1016/j.yebeh.2013.07.022
,2013, 'Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease', Oxidative Medicine and Cellular Longevity, http://dx.doi.org/10.1155/2013/102741
,2013, 'Uptake and mitochondrial dysfunction of alpha-synuclein in human astrocytes, cortical neurons and fibroblasts', Translational Neurodegeneration, 2, http://dx.doi.org/10.1186/2047-9158-2-20
,2013, 'Excitotoxicity in the Pathogenesis of Autism', Neurotoxicity Research, 23, pp. 393 - 400, http://dx.doi.org/10.1007/s12640-012-9354-3
,2013, 'Gliotoxicity of the cyanotoxin, â-methyl-amino-L-alanine (BMAA)', Scientific Reports, 3, pp. 1 - 5, http://dx.doi.org/10.1038/srep01482
,2013, 'Impaired Antioxidant Status and Reduced Energy Metabolism in Autistic Children', Research In Autism Spectrum Disorders, 7, pp. 557 - 565, http://dx.doi.org/10.1016/j.rasd.2012.12.006
,2013, 'Is Alzheimer’s a disease of the white matter?', Current Opinion in Psychiatry, 26, pp. 244 - 251, http://dx.doi.org/10.1097/YCO.0b013e32835ed6e8
,2013, 'P4–260: Neuroprotective effects of pomegranate juice extracts on quinolinic acid–induced excitotoxicity in human neurons', Alzheimer's & Dementia, 9, http://dx.doi.org/10.1016/j.jalz.2013.05.1653
,2013, 'P4–261: Anti‐oxidant and anti‐excitotoxic effects of date, fig and walnut extracts in human neurons', Alzheimer's & Dementia, 9, http://dx.doi.org/10.1016/j.jalz.2013.05.1654
,2013, 'P4–262: Neuro‐protective effects of pomegranate juice extracts on 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridin (MPTP)–induced neurotoxicity in human neurons', Alzheimer's & Dementia, 9, http://dx.doi.org/10.1016/j.jalz.2013.05.1655
,2013, 'Role of NAD+, Oxidative Stress and Tryptophan Metabolism in Autism Spectrum Disorders', International Journal of Tryptophan Research : IJTR, 6, pp. 1 - 14, http://dx.doi.org/10.4137/IJTR.S11355
,2013, 'The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease', Ageing Research Reviews, 12, pp. 867 - 883, http://dx.doi.org/10.1016/j.arr.2013.06.003
,2012, 'Age-associated changes in oxidative stress and NAD + metabolism in human tissue', PLoS One, 7, pp. e42357, http://dx.doi.org/10.1371/journal.pone.0042357
,2012, 'Excitotoxic potential of the cyanotoxin â-methyl-amino-l-alanine (BMAA) in primary human neurons', Toxicon, 60, pp. 1159 - 1165, http://dx.doi.org/10.1016/j.toxicon.2012.07.169
,2012, 'Kynurenine Pathway in Skin Cells: Implications for UV-Induced Skin Damage', International Journal of Tryptophan Research : IJTR, 5, pp. 15 - 25, http://dx.doi.org/10.4137/IJTR.S9835
,2012, 'NAD + metabolism and oxidative stress: The golden nucleotide on a crown of thorns', Redox Report, 17, pp. 28 - 46, http://dx.doi.org/10.1179/1351000212Y.0000000001
,2012, 'Neuroprotective Effect of Natural Products Against Alzheimer's Disease', Neurochemical Research, 37, pp. 1829 - 1842, http://dx.doi.org/10.1007/s11064-012-0799-9
,2012, 'Recent rodent models for Alzheimer's disease: Clinical implications and basic research', Journal of Neural Transmission, 119, pp. 173 - 195, http://dx.doi.org/10.1007/s00702-011-0731-5
,2012, 'Sirtuins in cognitive ageing and Alzheimer's disease', Current Opinion in Psychiatry, 25, pp. 226 - 230, http://dx.doi.org/10.1097/YCO.0b013e32835112c1
,2012, 'The kynurenine pathway in brain tumor pathogenesis', Cancer research, 72, pp. 5649 - 5657, http://dx.doi.org/10.1158/0008-5472.CAN-12-0549
,2011, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN HUMAN PRIMARY GLIOBLASTOMA PATHOGENESIS', NEURO-ONCOLOGY, 13, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297026600283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Evaluating the impact of new anticoagulants in the hospital setting', Pharmacy Practice, 9, pp. 1 - 10, http://dx.doi.org/10.4321/S1886-36552011000100001
,2011, 'Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats.', PLoS One, 6, pp. e19194, http://dx.doi.org/10.1371/journal.pone.0019194
,2011, 'Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats', FEBS Journal, 278, pp. 4425 - 4434, http://dx.doi.org/10.1111/j.1742-4658.2011.08366.x
,2011, 'Effects of Kynurenine Pathway Inhibition on NAD+ Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.', International Journal of Tryptophan Research : IJTR, 4, pp. 29 - 37, http://www.la-press.com/effects-of-kynurenine-pathway-inhibition-on-nad-metabolism-and-cell-vi-article-a2631
,2010, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE', JOURNAL OF NEUROCHEMISTRY, 115, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281812600096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons', FEBS Journal, 277, pp. 368 - 382, http://dx.doi.org/10.1111/j.1742-4658.2009.07487.x
,2010, 'P2‐251: Age‐related changes in NAD+ metabolism in the brain of aged Wister rats: Relevance for Alzheimer's disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.05.1301
,2010, 'P4‐002: Involvement of the Kynurenine Pathway in Alzheimer's Disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.08.063
,2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, 2, pp. 61 - 69
,2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes & neurons', Neurotoxicity Research, 16, pp. 77 - 86
,2009, 'P3‐195: Involvement of the kynurenine pathway in Alzheimer's disease', Alzheimer's & Dementia, 5, http://dx.doi.org/10.1016/j.jalz.2009.04.1069
,2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons', PLoS One, 4, pp. e6344 -1 - 15
,2008, 'Promotion of Cellular NAD Anabolism: Therapeutic Potential for Oxidative Stress in Aging & Alzheimer`s Disease', Neurotoxicity Research, 13, pp. 173 - 184
,